Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/23/19 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
25 | |
| 05/22/19 | 4/A | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/20/19 | 8-K | Current report filing |
|
10 | |
| 05/15/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
40 |
| 05/15/19 | 8-K | Current report filing |
|
11 | |
| 05/15/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/14/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/14/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/14/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
